Petroreconcavo S.A (RECV3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 12.80 |
|---|---|
| 52-week range | 9.39 – 14.64 |
| Return, 1 month / 3 months | +17.4% / +21.5% |
| Return, 1 year / 3 years | +11.4% / −17.7% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 34.3% |
| Worst drawdown (1 year) | -31.9% |
| Average daily value traded | 22.44M BRL |
| Dividend yield | 8.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Petroreconcavo is a Brazilian oil and gas company based in Bahia that focuses on onshore exploration and production in the Reconcavo Basin. It produces crude oil and natural gas from mature fields and operates gas processing and treatment facilities. The company supplies natural gas to industrial, commercial and other customers, and it also holds interests in onshore fields and related infrastructure. Its activities span upstream production, gas processing and the delivery of energy to regional markets in Brazil.
On this site Petroreconcavo S.A appears as a stock on the B3 Stock Exchange (Brazil), code RECV3, with prices in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Petroreconcavo S.A (RECV3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 12.80 on 23 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 407 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.4% and over the last three months it rose 21.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 16.1% | ||
| From 52-week high | -10.5% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 21.5% | ||
| 6-month return | -0.2% | ||
| 12-month return, skipping the last month | -5.1% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.9% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 22.44M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 8.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | +17.4% |
| 3 months | +21.5% |
| 6 months | −0.2% |
| 1 year | +11.4% |
| 3 years | −17.7% |
| 5 years | +26.6% |
Signals
| 50-day / 200-day average | 11.09 / 11.03 |
|---|---|
| Golden / death cross (60 days) | Golden, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.38 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Aug 2026 | BRL 0.3407 |
| 18 May 2026 | BRL 0.3408 |
| 8 Jan 2026 | BRL 0.3413 |
| 15 May 2025 | BRL 0.9001 |
| 12 Nov 2024 | BRL 1.2931 |
| 5 Jun 2024 | BRL 1.3988 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.